FDA-cleared profile

Brainomix 360 Hyperdensity

Brainomix Limited

Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.
FDA source Exact FDA submission Checked 2026-09-05
Intended users
Medical imaging professionals (trained clinicians) in a hospital/clinical environment
Public source Exact FDA submission Checked 2026-09-01

Intended-user text reported in the exact-submission ACR model card.

Care setting and population
Adult
Public source Exact FDA submission Checked 2026-09-01

Patient-population text reported in the exact-submission ACR model card; institutional setting may still require vendor confirmation.

Workflow role
Segmentation or contouring
Public source Exact FDA submission Checked 2026-08-31

Conservative normalization of explicit wording in an exact-submission source.

Required input
Adult single-timepoint non-contrast head CT.
FDA source Exact FDA submission Checked 2026-09-05
Output and human action
RGB overlay segmentation, summary DICOM series and hyperdensity volumes; overlay colors and volumes have no standalone clinical meaning.
FDA source Exact FDA submission Checked 2026-09-05
Limitations
Does not provide lateral-ventricle volume or midline shift and is not a replacement for physician image review.
FDA source Exact FDA submission Checked 2026-09-05

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K260406
FDA source Exact FDA submission Checked 2026-08-31
Modality
CT/CTA
FDA source Exact FDA submission Checked 2026-09-05
Anatomy
Brain
FDA source Exact FDA submission Checked 2026-09-05
Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2026-06-12
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
Automated DICOM routing sends original images and results to preconfigured PACS destinations; the DICOM Network Integration Module uses DICOM C-STORE.
FDA source Exact FDA submission Checked 2026-09-05
Deployment and data flow
Software may be deployed as a physical server or virtual-machine software appliance.
FDA source Exact FDA submission Checked 2026-09-05
Security and privacy
Vendor documentation pending
Vendor confirmation Exact product version Checked 2026-09-05

No scoped and dated security evidence was reviewed.

Training and support
Current Brainomix FAQ describes installation/go-live testing and group training/manuals for licensed users.
Vendor supplied Product family Checked 2026-09-05
Monitoring and change control
The PCCP permits model retraining and threshold adjustment within the cleared indications; models are locked before release and do not continuously learn.
FDA source Exact FDA submission Checked 2026-09-05

Family implementation support

Managed-appliance deployment, PACS protocol setup and go-live testing are described by the vendor.

product family · checked 2026-09-05

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
Regulatory segmentation agreement testing is submission-specific; clinical diagnostic-performance metrics were not abstracted.
FDA source Exact FDA submission Checked 2026-09-05
Reported sensitivity
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-05
Reported specificity
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-05

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Brainomix 360 Hyperdensity regulatory segmentation validation

Segmentation validation against trained-radiologist reference. · Adult non-contrast CT; cohort size not reported in the reviewed summary.

exact submission · Tested version: Brainomix 360 Hyperdensity configuration K260406 · Independence not established

K260406

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
Reviewed sources checked Exact product version Checked 2026-09-06
Reimbursement and coding
Research pending
Needs research Exact FDA submission Checked 2026-09-06

No applicable payer policy reviewed.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-06Last searched
22Fields reviewed
9Source classes checked
0Reviewed PubMed leads
0Reviewed trial leads
0Unreviewed FDA recall leads

No stored literature or trial candidates; empty metadata snapshots were screened. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, acr ai central product, fda decision summary, vendor product page, literature index, trial registry, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-05.

Alternatives

Related tools to compare

FDA-cleared K243378

Rapid MLS

iSchemaview Inc.

Brain midline-shift measurement on adult non-contrast CT

Modality
CT/CTA
Anatomy
Brain
Decision
2025-05-28
FDA-cleared K161322

CT CoPilot

ZEPMED, LLC.

CT CoPilotTM is intended for automatic labeling, visualization and volumetric quantification of segmentable structures from sets of CT images of the brain.

Modality
CT/CTA
Anatomy
Brain
Decision
2016-12-07
FDA-cleared K253818

Annalise Enterprise

Harrison-AI Medical Pty, Ltd.

Annalise Enterprise prioritizes and notifies trained CT clinicians of suspected acute infarct on non-contrast brain CT for adults; it is a study-level, non-localizing worklist aid...

Modality
CT/CTA
Anatomy
Brain
Decision
2026-03-03